Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth Considering

Even though hematogenous spread of the Lyme disease spirochete, Borrelia burgdorferi, has been well documented, and there are more than 300,000 cases per year of Lyme disease in the United States, no evidence (anecdotal or published) of transfusion-associated Lyme disease has been reported. Such a p...

Full description

Bibliographic Details
Main Authors: Charles S. Pavia, Maria M. Plummer
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.02070/full
id doaj-20ee94285319413d949bb1f807618e7b
record_format Article
spelling doaj-20ee94285319413d949bb1f807618e7b2020-11-24T21:21:31ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2018-09-01910.3389/fmicb.2018.02070409118Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth ConsideringCharles S. Pavia0Maria M. Plummer1Department of Biomedical Sciences, New York Institute of Technology College of Osteopathic Medicine, New York, NY, United StatesDepartment of Clinical Specialties, New York Institute of Technology College of Osteopathic Medicine, New York, NY, United StatesEven though hematogenous spread of the Lyme disease spirochete, Borrelia burgdorferi, has been well documented, and there are more than 300,000 cases per year of Lyme disease in the United States, no evidence (anecdotal or published) of transfusion-associated Lyme disease has been reported. Such a possibility would seem to exist but various factors, as discussed in this perspective, make this less likely to occur. Nonetheless, if not done already, safeguards need to be put in place at blood collection and dispensing facilities, possibly with the assistance of diagnostic microbiology and immunology laboratories, to ensure that the potential for the transfer of the Lyme disease spirochete through a blood transfusion remains a theoretical consideration rather than a real possibility.https://www.frontiersin.org/article/10.3389/fmicb.2018.02070/fulllyme diseaseBorrelia burgdorferihematogenous spreadblood donorblood transfusiondiagnostic testing
collection DOAJ
language English
format Article
sources DOAJ
author Charles S. Pavia
Maria M. Plummer
spellingShingle Charles S. Pavia
Maria M. Plummer
Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth Considering
Frontiers in Microbiology
lyme disease
Borrelia burgdorferi
hematogenous spread
blood donor
blood transfusion
diagnostic testing
author_facet Charles S. Pavia
Maria M. Plummer
author_sort Charles S. Pavia
title Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth Considering
title_short Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth Considering
title_full Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth Considering
title_fullStr Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth Considering
title_full_unstemmed Transfusion-Associated Lyme Disease – Although Unlikely, It Is Still a Concern Worth Considering
title_sort transfusion-associated lyme disease – although unlikely, it is still a concern worth considering
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2018-09-01
description Even though hematogenous spread of the Lyme disease spirochete, Borrelia burgdorferi, has been well documented, and there are more than 300,000 cases per year of Lyme disease in the United States, no evidence (anecdotal or published) of transfusion-associated Lyme disease has been reported. Such a possibility would seem to exist but various factors, as discussed in this perspective, make this less likely to occur. Nonetheless, if not done already, safeguards need to be put in place at blood collection and dispensing facilities, possibly with the assistance of diagnostic microbiology and immunology laboratories, to ensure that the potential for the transfer of the Lyme disease spirochete through a blood transfusion remains a theoretical consideration rather than a real possibility.
topic lyme disease
Borrelia burgdorferi
hematogenous spread
blood donor
blood transfusion
diagnostic testing
url https://www.frontiersin.org/article/10.3389/fmicb.2018.02070/full
work_keys_str_mv AT charlesspavia transfusionassociatedlymediseasealthoughunlikelyitisstillaconcernworthconsidering
AT mariamplummer transfusionassociatedlymediseasealthoughunlikelyitisstillaconcernworthconsidering
_version_ 1725999506935250944